The drugmaker said it would spend up to $4 billion to acquire small companies exploring vaccines for shingles, Epstein-Barr virus and other pathogens.
Eli Lilly to Buy 3 Vaccine Developers
Originally reported by New York Times
Related Articles
The Guardian view on Britain’s economy: to profit politically a recovery must be felt in people’s pockets | Editorial
The chancellor can point to growth and lower inflation, but weak job data, flat living standards and uncertain productiv...
A pension system that is unfair and unaffordable | Letters
Guardian readers respond to an article by Zoe Williams which argued that cutting the welfare bill should start with pens...
American Airlines picks SpaceX's Starlink for in-flight Wi-Fi on more than 500 planes
American Airlines plans to outfit more than 500 of its narrow-body aircraft with Starlink, handing another win to Elon M...
SpaceX’s Unconventional Corporate Arrangements Favor Elon Musk
The ways it set up its board and Mr. Musk’s pay appear to benefit him at the expense of other shareholders, corporate go...